Physician

Alexander C Fanaroff, M.D., M.H.S.

According to 2025 Medicare claims, Alexander Fanaroff, M.D., M.H.S. (NPI: 1275822181) practices interventional cardiology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is UNIVERSITY OF PENN - MEDICAL GROUP (NPI: 1093725145; TIN: 232743545) and primary practice location at 19104-4208.

Fanaroff's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 205 traditional Medicare patients, billed 507 HCPCS/CPT codes, and received $39,462 in Medicare payments. The top billing code was 93451 (Insertion of tube in right heart chambers for measurement). Part D data shows 171 prescription claims across 36 beneficiaries totaling $34,233 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 12 claims. Open Payments data shows 27 records totaling $2,852. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $7,803 and ending at $34,233. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	148	312	$25,298
2020	305	574	$43,800
2021	292	644	$54,127
2022	338	693	$59,692
2023	219	497	$42,066
2024	205	507	$39,462

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	29	94	$7,803
2016	36	221	$19,630
2017	12	70	$6,886
2018	N/R	27	$208
2019	N/R	N/R	N/R
2020	11	37	$1,298
2021	19	56	$3,771
2022	32	133	$21,199
2023	34	80	$12,507
2024	36	171	$34,233

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	11	$743
2023	N/R	12	$840
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93451	Insertion of tube in right heart chambers for measurement	44	47	$101
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	34	49	$65
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	36	46	$12
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	98	106	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	68	88	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	12	660	$12,123
Carvedilol	Carvedilol	13	900	$240
Atorvastatin Calcium	Atorvastatin Calcium	23	1,410	$204
Metoprolol Succinate	Metoprolol Succinate	15	1,350	$139
Rosuvastatin Calcium	Rosuvastatin Calcium	11	990	$100

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	27	$2,852	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alexander C. Fanaroff, M.D., M.H.S.?

Tedicare shows public-source Medicare data for Alexander C. Fanaroff, M.D., M.H.S. (NPI 1275822181), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexander C. Fanaroff, M.D., M.H.S. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alexander C. Fanaroff, M.D., M.H.S.?

Alexander C. Fanaroff, M.D., M.H.S. is linked to UNIVERSITY OF PENN - MEDICAL GROUP (billing NPI 1093725145) in the available physician profile data.

Does Alexander C. Fanaroff, M.D., M.H.S. have Open Payments data?

Alexander C. Fanaroff, M.D., M.H.S. has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.